Skip to main content

Table 5 Predictors of non HDL-C goal attainment

From: First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients

 

Initial model

Final model

 

OR (95% CIs)

P-value

OR (95% CIs)

P-value

Male gender

1.04 (0.50-2.17)

0.9

  

Age

1.01 (0.98-1.05)

0.4

  

DM

0.78 (0.33-1.87)

0.6

  

Smoking

0.65 (0.31-1.36)

0.2

  

CAD

1.61 (0.75-3.45)

0.2

1.80 (0.95-3.42)

0.07

PAD

1.71 (0.62-4.66)

0.3

  

Cerebrovascular disease

0.64 (0.17-2.35)

0.5

  

Baseline LDL-C (mg/dl)

0.98 (0.97-0.99)

0.001

0.98 (0.97-0.99)

<0.001

Combined therapy with statin and ezetimibe

1.92 (0.81-4.56)

0.1

  

Very high potency LDL-C lowering regimen

1.06 (0.36-3.10)

0.9

  

Fenofibrate

1.05 (0.34-3.42)

0.9

  

n3 fatty acids

    
  1. DM = diabetes mellitus, CAD = coronary artery disease, PAD = peripheral arterial disease, LDL-C = low density lipoprotein-cholesterol.